发明名称 |
Crystalline form of biphenyl compound |
摘要 |
Disclosed is a crystalline 1,2-ethanedisulfonic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenylcarbamoyl)ethyl]piperidin-4-yl ester or a solvate thereof. Further disclosed is a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound as defined above and which optionally comprises a steroidal anti-inflammatory agent such as 6a,9a-difluoro-17a-[(2-furanylcarbonyl)oxy]-11b-hydroxy-16a-methyl-3-oxoandrosta-1,4-diene-17b-carbothioic acid S-fluoromethyl ester or a solvate thereof.
|
申请公布号 |
NZ552796(A) |
申请公布日期 |
2010.09.30 |
申请号 |
NZ20050552796 |
申请日期 |
2005.08.15 |
申请人 |
THERAVANCE, INC. |
发明人 |
CHAO, ROBERT S;RAPTA, MIROSLAV;COLSON, PIERRE-JEAN |
分类号 |
A61K31/4709;A61P11/00;C07D211/46;C07D215/22;C07D215/26;C07D401/12 |
主分类号 |
A61K31/4709 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|